View all blogs:
Croda welcomes Thomas Riermeier as new President of Life Sciences
Pharma
Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=4F9521E2A9CDAB872D1AA12B9BA9F4EB)
From Lab to Patient: Optimising Oncology Formulations with Purified Excipients
Pharma
In 2024, we hosted a live webinar exploring the impact of our Super RefinedTM excipients on various chemotherapeutic formulations. This blog will explore some of the key learnings from the webinar.
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=F330DFD631D5F6E81578038D37E005ED){kind=logo}
Croda’s Avanti Research expands ionizable lipid offering for LNP drug development through Certest collaboration
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and Certest Biotec S.L. (Certest) are pleased to announce a strategic collaboration to expand the market’s access to...
Protein Leader: Garima Sinha
Pharma
In our latest edition of Protein Leaders, we speak to Garima Sinha. Keep reading to learn more...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=1A76ADAC46124CA8DF3A96C10265D3C2)
Heart Health month
Pharma
February marks Heart Month, this global initiative looks to educate the population on heart disease and what preventative measures can be taken to improve cardiovascular health. In this blog, we...
Plant cholesterol – The future of lipid-based drug delivery
Pharma
While cholesterol is undeniably a key player in lipid formulations, effective across various dosage routes and genetic delivery applications, an important question remains: does the source of...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A64095A181C3A54A0679D38F67C4CA0E)
Lipids Leader: Rasmus Münter, PhD - Lead Research Scientist
Pharma
In our latest edition of Lipid Leaders, we speak to Rasmus Münter, PhD. Rasmus is a lipid-based nanoparticle and vaccine adjuvant expert based in Denmark for Croda Pharma. Keep reading to learn more...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=51D19B4B65B031475D93DBD45F1F23DC)
Insights into the veterinary health market
Pharma
The veterinary market in the EMEA region is expected to experience substantial growth in the coming years: 5-8% CAGR. Typically, the veterinary market is categorised into companion animals and...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=D964AC649BA30C623822E347ADA7FD18)
World Cancer Day 2025
Pharma
In 2022 alone, 9.7 million people worldwide lost their lives to cancer, and the number of new cases is expected to rise to nearly 30 million by 2040. It is a disease that takes so much from so many,...
Croda opens advanced lipids manufacturing facility in Pennsylvania
Pharma
PRESS RELEASE: 15 January 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announces the...
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
Pharma
PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...
Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture
Pharma
Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.
Announcing Avanti Research - a Croda brand
Pharma
Avanti Polar Lipids, a global leader in lipids, has announced its renewed offering for researchers and its transformation to Avanti Research.
The Oral Hygiene market is evolving
Pharma
Growth in the oral hygiene market is mainly focused around two main categories: toothpastes and mouthwashes. The global oral hygiene market size was valued at USD 31.7 billion in 2020 and is expected...
EXCLUSIVE WHITEPAPER: Next-generation Triton™ X-100 replacements for pharmaceutical bioprocessing
Pharma
Triton™ X-100 (tert-octyl phenyl ethoxylate) is used extensively in the manufacture of biologics, plasma-derived products and cell and gene therapies (CGTs). This non-ionic detergent is used because...
Veterinary vaccines - solutions for an ongoing challenge...
Pharma
Growth in the veterinary pharmaceutical industry continues to be driven by increasing pet ownership globally and the rising demand for veterinary vaccines to prevent the risk of zoonotic diseases in...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A3F1E1F41A1C690A537D793D09D9F2EA)
QbD Formulation Development
Pharma
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A303EDE921EF0283547DD585579EDC71)
Targeted lipid nanoparticles in Nucleic Acid Delivery
Pharma
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Croda joins CGT Catapult consortium to improve AAV formulation
Pharma
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Pharma
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...
Product Spotlight - Crodamol™ CCC Pharma
Pharma
Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.
Lipid Leaders: Söhnke Voss
Pharma
In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=DED45BB0A21246A9E305B87AC705FA5A)
Protein Delivery Leaders: Andrew Bright
Pharma
In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.
Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards
Pharma
Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
Pharma
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Pharma
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Product Spotlight - Super Refined PEG 400
Pharma
Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...
Specializing in specific enhancement technologies
Pharma
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
Explore our latest downloads!
Pharma
Check out the latest resources from Croda Pharma, available to download today.
Hear directly from our experts...
Pharma
Watch our expert Dr. Kritika Bajaj discuss our product range in more detail and learn how Virodex™ could be the solution to your replacement requirement.
Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world
Pharma
Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications...
“Close the Care Gap” – World Cancer Day 2024
Pharma
We are proud to continue supporting the development of cancer treatments, and on this World Cancer Day, recognise the importance of innovation and science to cure and treat those diagnosed. Together,...
Spotlight on Kritika Bajaj
Pharma
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...
Croda’s response to Sustainable Markets Initiative for supplier sustainability targets
Pharma
The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...
Sustainability for vaccines: Decarbonisation of one of our key sites
Pharma
Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...
A powerful match - celebrating three years of Croda Pharma and Avanti
Pharma
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...
Introducing new bioprocessing solutions to replace banned materials
Pharma
We have introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need...
Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Pharma
Cholesterol, a key component in lipid-based drug delivery systems, provides structural support and stability, enhances the efficiency of intracellular delivery and gene transfection.
Acquisition of Solus Biotech expands specialised Pharma business in Asia
Pharma
05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials
Acquisition of Solus Biotech strengthens Croda Pharma
Pharma
On 04 July Croda successfully completed the acquisition of Solus Biotech, an innovative biotechnology company with over three decades of industry experience.
Croda opens new Global Technical Centre at Genome Valley, Hyderabad, India
Pharma
PRESS RELEASE – On June 21, 2023, Croda International Plc opened its new Global Technical Centre at Genome Valley, Hyderabad, India.
Croda breaks ground on new manufacturing facility for pharmaceutical excipients in Lamar, Pennsylvania
Pharma
31st May 2023: Croda, Inc., the company that uses smart science to create high-performance ingredients and solutions that improve lives, broke ground on 9 May 2023, its newest manufacturing facility...
From Triton X-100 to Virodex: exploring our innovative solution to the Triton X-100 ban
Pharma
For those who have previously relied on Triton™ X-100 as a surfactant or detergent in their manufacturing processes there is now an urgent need to find a suitable replacement. Explore Croda's...
Unleashing the future of vaccines: MVADS 2023
Pharma
We are proud to be a sponsor for Modern Vaccines Adjuvants and Delivery Systems (MVADS 2023). Taking place in Copenhagen from May 31st to June 2nd, this global conference will focus on sharing the...
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Pharma
19 May 2023: Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain...
The future of mRNA delivery: Advancements in engineering lipid nanoparticles for enhanced intracellular delivery through inhalation
Pharma
Messenger RNA (mRNA) has played a crucial role in recent vaccine developments and is at the forefront of much current medical research. Traditionally. the delivery of mRNA systemically via lipid...
Oral Drug Delivery
Pharma
The oral route of administration presents a convenient, cost-effective, and non-invasive method for delivering drugs. However, with the increasing complexity of APIs, the delivery of these drugs also...
Revolutionizing gene editing: How RGD peptide-based lipids could be the key to effective mRNA delivery
Pharma
Gene editing has emerged as a promising strategy for treating a wide range of genetic disorders. However, the efficacy of gene therapy is limited by the challenge of delivering therapeutic agents to...
Precision medicine revolution: The potential of DSPE-RGD in targeted drug delivery
Pharma
In recent years, researchers and clinicians have been exploring new ways to deliver drugs directly to the cells and tissues that need them, while minimizing side effects on healthy cells. One of the...
TIDES 2023
Pharma
We can't wait to see you at TIDES! Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire...
Promising new results for metastatic prostate cancer vaccine
Pharma
A new study1 published in Frontiers in Immunology reports promising vaccine results for patients with hormone-sensitive prostate cancer. The researchers demonstrated that a vaccine formulation...
Consumer Health at Croda Pharma - over 100 years of heritage
Pharma
For the Consumer Health team, our main goal is to help our customers market consumer relevant claims that grow their product and brand authority.
Women in STEM - Maths
Pharma
Meet some of the women in maths-facing roles across our business as part of our Women in STEM series.
Women in STEM - Engineering
Pharma
Meet some of the women in engineering roles across our business as part of our Women in STEM series.
Women in STEM - Technology
Pharma
Meet some of the women in technology roles across our business as part of our Women in STEM series.
#SmashingStereotypes - our take!
Pharma
As part of British Science Week, BSA are aiming to smash stereotypes through interviewing a diverse range of scientists. Who do you think of when you picture a scientist?
International Women's Day
Pharma
International Women’s Day is marked on the 8th March and highlights a number of missions to help forge a gender equal world, by celebrating women’s achievements and increasing visibility while calling...
Lipids in Small-Molecule Pro-Drugs
Pharma
Lipids are used in therapeutics in many ways. Some lipids have even been used as small-molecule drugs to treat specific diseases, and are also being used to improve undesirable characteristics of...
Our veterinary health offering
Pharma
We are the global partner for high quality excipients, adjuvant systems and formulation support for the animal health industry, and we are continuously innovating to provide break-through solutions...
Croda Pharma welcomes Dave Cherry
Pharma
We warmly welcome Dave Cherry as our new Global Managing Director. David brings with him past experiences from his work with the wider Life Sciences Leadership Team and healthcare markets, which is...
Introducing our Adjuvant Systems Platform
Pharma
Introducing our Adjuvant Systems platform. Leveraging a history of developing adjuvants since 1939, our scientists deliver high performance adjuvants to meet your vaccine needs today.
World Cancer Day 2023
Pharma
World Cancer Day, observed on the 4th February is led by the Union for International Cancer Control (UICC) and aims to save millions of preventable deaths each year by raising awareness and improving...
Introducing our Nucleic Acid Delivery platform
Pharma
This post introduces our Nucleic Acid Delivery platform, a technology area that was strengthened through our acquisition of Avanti Polar Lipids in 2020.
Croda Pharma: The future of novel excipients
Pharma
The importance of excipients and their specialised role in formulation development has been recognised in recent years, whether that be for targeting delivery of the drug, aesthetics of the final...
Expert Q&A - Dr Stephen Rumbelow:
Pharma
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs...
Lipid technology for delivery of gene editing therapies
Pharma
Gene-editing is one of the most eagerly anticipated biopharma developments in recent history. However, one of the biggest hurdles to the development of successful gene-editing therapeutics is...
Excipient sustainability - A user and a supplier perspective
Pharma
To achieve their sustainability ambitions excipient users need to access excipients produced with lower embedded GHG emissions, little or no waste produced and with minimal impact on water quality and...
International Human Solidarity Day
Pharma
As part of Croda’s commitment to being Climate, Land and People Positive by 2030 we have developed targets linked to the UN SDGs. This blog post will focus on our People Positive commitment. We sat...
Qualifying the EXCiPACT Certification Scheme
Pharma
There has always been a regulatory requirement for Pharmaceutical manufacturers to audit their starting material suppliers, but with increasing and sustained use of 3rd party audit solutions,...
Things to consider when choosing a cationic lipid for your formulation
Pharma
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
International Volunteer Day - Croda's STEM Programme
Pharma
In light of International Volunteer Day on the 5th of December, we highlight the Croda STEM Programme, founded on our purpose of using 'Smart science to improve lives'
Innovative lipids for your nucleic acid delivery research
Pharma
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
Introducing our Small Molecule Delivery platform
Pharma
Our offering for Small Molecule Delivery focuses on tackling your formulation challenges and enhancing drug delivery through our high purity Super Refined™ excipients. Over the years, enhancing...
Lipid Leaders: Dennis Christensen
Pharma
In this Lipid Leaders interview, we get insight from Croda Pharma's own Global Head of R&D - Adjuvant Systems, Dennis Christensen, PhD. Keep reading to learn more about adjuvants and the role they...
Croda Pharma on the road at CPHI, Frankfurt
Pharma
We recently had the pleasure of exhibiting at CPHI Frankfurt. The event spanned over three days, uniting exhibitors at the heart of pharma and thousands of attendees for an extensive exhibition and...
Proprietary purification process extends formulation shelf life
Pharma
Formulating generic drugs of equivalent stability, safety, bioequivalence, and dosage form as originator drugs can be a great challenge. James Humphrey, Research and Technology Specialist explores how...
Our Healthcare division becomes Croda Pharma
Pharma
Croda International Plc, the company that uses smart science to create high performance ingredients and solutions that improve lives, has today announced that its Health Care division will now become...
Croda Pharma wins prestigious “Best Supplier for COVID-19 Vaccine Development 2022” Award
Pharma
Croda, the company that uses smart science to improve lives, announces that it has been awarded winner a prestigious award for its work in supporting vaccine development. The company has been awarded...
Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants
Pharma
Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental...
Croda expands its high purity pharmaceutical excipients manufacturing capability
Pharma
This investment confirms Croda’s commitment to building its Life Sciences business and developing innovative pharmaceutical excipients, reinforcing Croda’s Purpose to use Smart science to improve...
Strengthening Life Sciences with the acquisition of Avanti Polar Lipids
Pharma
13 August 2020: A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.